Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Tycho Heimbach, PhD
Sr Principal Scientist
Merck & Co Inc
Poster(s):
149: Bioequivalence Safe Space Assessment of Molnupiravir & NHC Using Physiologically Based Biopharmaceutics Modeling
Monday, September 11, 2023
5:00 PM - 7:00 PM
PT